Total Pharmacy |

The event will focus on revenue stream diversification, providing independent pharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.

Joey Mattingly, PharmD, MBA, PhD, and Marta Wosinska, PhD, discussed what pharmacy businesses can do to prepare for the potential implementation of tariffs on pharmaceutical products.

Drug Topics was joined by Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, to discuss the potential impact tariffs may have if they are widely implemented within the pharmaceutical industry.

In the suit, the companies claim the law puts an unconstitutional restriction on interstate commerce.

In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.

Alecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how they’ve impacted pharmacists and their businesses.

Michael Hegener, PharmD, BCACP, discusses how workforce development can best address the evolving knowledge, skills, and abilities needed in community pharmacy practice.

Researchers evaluated PBM reimbursement practices in Medicare and whether they resulted in out-of-pocket cost increases for Part D beneficiaries.

Michael Hegener, PharmD, BCACP, discusses what workflow changes are essential to support the expansion of patient care services in community pharmacies.

Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.

David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.

Michael Hegener, PharmD, BCACP, discusses how collaboration with health plans and pharmacy employers can enhance the implementation of practice redesign initiatives.

PBM expert Antonio Ciaccia, president of 3 Axis Advisors and CEO of 46brooklyn Research, discussed recent events in the pharmacy benefits industry and how it is moving toward PBM reform.

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discussed his role in uncovering PBM practices and pharmacy consulting.

A conversation with Kaitlin Bates, PharmD, ARHOME Quality Manager at Arkansas Blue Cross and Blue Shield, at PQA 2025.

Researchers aim to understand how deprescribing interventions impacted changes in inappropriate medication use or total prescription drugs among older, community-dwelling adults.

A conversation with Michael Hegener, PharmD, BCACP, associate professor of Pharmacy at the University of Cincinnati, at PQA 2025.

The announcement comes shortly after the company announced it had filed its second chapter 11 bankruptcy in under 2 years.

Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.

Rick Sage, Executive Vice President of Innovation & Standards at NCPDP, discusses his role and how his team is using innovation to support the pharmacy profession.

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.

In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists’ role in remote patient care amid a growing technological infrastructure.

In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.

In her expertise as a leader with the American Pharmacists Association, Brigid Groves, PharmD, MS, provides insights into her work with geographical information systems and maps.

Vin Gupta, MD, discusses trends and perspectives in patient data privacy as well as what a “smart pharmacy” may look like in the near future.

Cami Agena, Esq, and Candida Ruesga, Esq, discuss pharmacy benefit manager reform by providing insights from their experience as legal partners in complex PBM matters.

Larry King, PharmD, discusses how pharmacy interoperability is working to create collaborative care and get pharmacists “in the game” as he says.